SAFE & GREEN HOLDINGS CORP (SGBX)

US78418A5056 - Common Stock

5.54  +2.61 (+89.08%)

Premarket: 5.84 +0.3 (+5.42%)

Fundamental Rating

1

SGBX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 41 industry peers in the Construction & Engineering industry. Both the profitability and financial health of SGBX have multiple concerns. SGBX is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year SGBX has reported negative net income.
SGBX had a negative operating cash flow in the past year.
In the past 5 years SGBX always reported negative net income.
SGBX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -64.81%, SGBX is not doing good in the industry: 97.50% of the companies in the same industry are doing better.
SGBX's Return On Equity of -298.42% is on the low side compared to the rest of the industry. SGBX is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
ROA -64.81%
ROE -298.42%
ROIC N/A
ROA(3y)-26.6%
ROA(5y)-45.6%
ROE(3y)-45.02%
ROE(5y)-72.43%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SGBX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

SGBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGBX has more shares outstanding
The number of shares outstanding for SGBX has been increased compared to 5 years ago.
Compared to 1 year ago, SGBX has a worse debt to assets ratio.

2.2 Solvency

SGBX has an Altman-Z score of -5.02. This is a bad value and indicates that SGBX is not financially healthy and even has some risk of bankruptcy.
SGBX has a worse Altman-Z score (-5.02) than 95.00% of its industry peers.
A Debt/Equity ratio of 1.83 is on the high side and indicates that SGBX has dependencies on debt financing.
The Debt to Equity ratio of SGBX (1.83) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF N/A
Altman-Z -5.02
ROIC/WACCN/A
WACC9.67%

2.3 Liquidity

SGBX has a Current Ratio of 0.45. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
SGBX has a worse Current ratio (0.45) than 97.50% of its industry peers.
A Quick Ratio of 0.43 indicates that SGBX may have some problems paying its short term obligations.
With a Quick ratio value of 0.43, SGBX is not doing good in the industry: 97.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.43

5

3. Growth

3.1 Past

The earnings per share for SGBX have decreased strongly by -65.15% in the last year.
Looking at the last year, SGBX shows a very negative growth in Revenue. The Revenue has decreased by -35.03% in the last year.
SGBX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.97% yearly.
EPS 1Y (TTM)-65.15%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-27.78%
Revenue 1Y (TTM)-35.03%
Revenue growth 3Y101.53%
Revenue growth 5Y36.97%
Revenue growth Q2Q-3.99%

3.2 Future

Based on estimates for the next years, SGBX will show a very negative growth in Earnings Per Share. The EPS will decrease by -26.88% on average per year.
Based on estimates for the next years, SGBX will show a very strong growth in Revenue. The Revenue will grow by 48.36% on average per year.
EPS Next Y-174.47%
EPS Next 2Y-68.22%
EPS Next 3Y-26.88%
EPS Next 5YN/A
Revenue Next Year15.02%
Revenue Next 2Y53.11%
Revenue Next 3Y48.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGBX. In the last year negative earnings were reported.
Also next year SGBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SGBX's earnings are expected to decrease with -26.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.22%
EPS Next 3Y-26.88%

0

5. Dividend

5.1 Amount

SGBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SAFE & GREEN HOLDINGS CORP

NASDAQ:SGBX (5/3/2024, 7:18:01 PM)

Premarket: 5.84 +0.3 (+5.42%)

5.54

+2.61 (+89.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.54M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.81%
ROE -298.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.45
Quick Ratio 0.43
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-65.15%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-174.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-35.03%
Revenue growth 3Y101.53%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y